One Cerevel Therapeutics Holdings, Inc. insider upped their stake by 148 percent in the previous year - Yahoo Lifestyle UK
About 67% of Cerevel Therapeutics' investor base is looking to short. The analysis of current outlook of investing in Cerevel Therapeutics Holdings suggests that many traders are alarmed regarding Cerevel Therapeutics' prospects. The current market sentiment, together with Cerevel Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Cerevel Therapeutics stock news signals to limit their universe of possible portfolio assets.
Cerevel |
One Cerevel Therapeutics Holdings, Inc. insider upped their stake by 148 percent in the previous year Yahoo Lifestyle UK
Read at news.google.com
Cerevel Therapeutics Fundamental Analysis
We analyze Cerevel Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cerevel Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cerevel Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Cerevel Therapeutics is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Cerevel Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cerevel Therapeutics stock to make a market-neutral strategy. Peer analysis of Cerevel Therapeutics could also be used in its relative valuation, which is a method of valuing Cerevel Therapeutics by comparing valuation metrics with similar companies.
Peers
Cerevel Therapeutics Related Equities
IGMS | IGM Biosciences | 7.47 | ||||
MLYS | Mineralys Therapeutics, | 5.64 | ||||
DSGN | Design Therapeutics | 4.67 | ||||
APLS | Apellis Pharmaceuticals | 4.39 | ||||
TVTX | Travere Therapeutics | 4.04 | ||||
GPCR | Structure Therapeutics | 2.38 | ||||
BPMC | Blueprint Medicines | 1.29 | ||||
SWTX | SpringWorks Therapeutics | 0.94 | ||||
STOK | Stoke Therapeutics | 0.33 | ||||
DAWN | Day One | 0.65 | ||||
IKNA | Ikena Oncology | 1.16 | ||||
GLUE | Monte Rosa | 1.35 | ||||
TERN | Terns Pharmaceuticals | 1.44 | ||||
HOWL | Werewolf Therapeutics | 2.00 | ||||
CGEM | Cullinan Oncology | 2.08 | ||||
NUVL | Nuvalent | 2.49 | ||||
RNA | Avidity Biosciences | 4.02 | ||||
VTYX | Ventyx Biosciences | 5.97 | ||||
RVMD | Revolution Medicines | 10.46 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Cerevel Stock
If you are still planning to invest in Cerevel Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cerevel Therapeutics' history and understand the potential risks before investing.
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |